These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25956728)

  • 1. Severe Acute Orthopnea: Ipilimumab-Induced Bilateral Phrenic Nerve Neuropathy.
    Jinnur P; Lim KG
    Lung; 2015 Aug; 193(4):611-3. PubMed ID: 25956728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failing phrenics: an obscure cause of exertional dyspnea: Case report and literature review.
    Rafiq A; Ijaz M; Tariq H; Vakde T; Duncalf R
    Medicine (Baltimore); 2016 Jul; 95(29):e4263. PubMed ID: 27442657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral phrenic nerve paralysis manifested by orthopnea for 6 months in a patient with neuralgic amyotrophy.
    Ikegami G; Abe T; Akasaka K; Kouyama A; Souma R; Matsuo T; Kouyama K; Fujiwara H; Ichiwata T; Nagao K
    Intern Med; 2009; 48(24):2123-7. PubMed ID: 20009405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual case of orthopnea.
    Keelan E; Kidney J; Judge EP
    Clin Med (Lond); 2017 Jun; 17(3):245-247. PubMed ID: 28572225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of immune-related adverse events and kinetics of response with ipilimumab.
    Weber JS; Kähler KC; Hauschild A
    J Clin Oncol; 2012 Jul; 30(21):2691-7. PubMed ID: 22614989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bilateral phrenic neuropathy following treatment with adalimumab.
    Alexopoulou A; Koskinas J; Soultati A; Katsaounis P; Kilidireas K; Papageorgiou C; Antoniou C; Katsambas A; Archimandritis A
    Clin Rheumatol; 2009 Nov; 28(11):1337-40. PubMed ID: 19669617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnea as the predominant manifestation of bilateral phrenic neuropathy.
    Kumar N; Folger WN; Bolton CF
    Mayo Clin Proc; 2004 Dec; 79(12):1563-5. PubMed ID: 15595343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma.
    Ranganath HA; Panella TJ
    J Immunother; 2015 Jun; 38(5):211. PubMed ID: 25962109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma.
    Roth ME; Muluneh B; Jensen BC; Madamanchi C; Lee CB
    Am J Ther; 2016; 23(6):e1925-e1928. PubMed ID: 26885708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ipilimumab and celiac disease.
    Gentile NM; D'Souza A; Fujii LL; Wu TT; Murray JA
    Mayo Clin Proc; 2013 Apr; 88(4):414-7. PubMed ID: 23541015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A severe case of ipilimumab-induced guillain-barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis.
    Gaudy-Marqueste C; Monestier S; Franques J; Cantais E; Richard MA; Grob JJ
    J Immunother; 2013 Jan; 36(1):77-8. PubMed ID: 23211620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral isolated phrenic neuropathy causing painless bilateral diaphragmatic paralysis.
    Lin PT; Andersson PB; Distad BJ; Barohn RJ; Cho SC; So YT; Katz JS
    Neurology; 2005 Nov; 65(9):1499-501. PubMed ID: 16275847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipilimumab-induced colitis in patients with metastatic melanoma.
    De Felice KM; Gupta A; Rakshit S; Khanna S; Kottschade LA; Finnes HD; Papadakis KA; Loftus EV; Raffals LE; Markovic SN
    Melanoma Res; 2015 Aug; 25(4):321-7. PubMed ID: 25933207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma.
    Modjtahedi BS; Maibach H; Park S
    Cutan Ocul Toxicol; 2013 Oct; 32(4):341-3. PubMed ID: 23713627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phrenic neuropathy water immersion dyspnea: Clinical findings and need for patient counseling.
    Vazquez Do Campo R; Shelly S; Boon AJ; Mandrekar J; Vassallo R; Klein CJ
    Neurology; 2020 Mar; 94(12):e1314-e1319. PubMed ID: 31992683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipilimumab-induced Ocular and Orbital Inflammation--A Case Series and Review of the Literature.
    Papavasileiou E; Prasad S; Freitag SK; Sobrin L; Lobo AM
    Ocul Immunol Inflamm; 2016; 24(2):140-6. PubMed ID: 25760920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.
    Horvat TZ; Adel NG; Dang TO; Momtaz P; Postow MA; Callahan MK; Carvajal RD; Dickson MA; D'Angelo SP; Woo KM; Panageas KS; Wolchok JD; Chapman PB
    J Clin Oncol; 2015 Oct; 33(28):3193-8. PubMed ID: 26282644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipilimumab-induced acute severe colitis treated by infliximab.
    Pagès C; Gornet JM; Monsel G; Allez M; Bertheau P; Bagot M; Lebbé C; Viguier M
    Melanoma Res; 2013 Jun; 23(3):227-30. PubMed ID: 23458760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febrile neutropenia in a metastatic melanoma patient treated with ipilimumab - case report.
    Woźniak S; Mackiewicz-Wysocka M; Krokowicz Ł; Kwinta Ł; Mackiewicz J
    Oncol Res Treat; 2015; 38(3):105-8. PubMed ID: 25792081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual pulmonary toxicity of ipilimumab treated by macrolides.
    Mailleux M; Cornélis F; Colin GC; Baurain JF
    Acta Clin Belg; 2015 Dec; 70(6):442-4. PubMed ID: 26790556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.